TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32800891

Group type: EXPERIMENTAL
Intervention: Maximal treadmill walking test with Gardner's protocol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (standing on treadmill)
Number of subjects: 40
Study: 32343190

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 72)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Wellness education control condition (n = 64)
Number of subjects: 136
Study: 34030899

Group type: EXPERIMENTAL
Intervention: Cold pack kept in the refrigerator applied to the area above the IV catheter before drug infusion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cold pack kept at room temperature applied in the placebo group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine drug infusion without cold application in the control group
Number of subjects: 120
Study: 32944806

Group type: EXPERIMENTAL
Intervention: Dual-site rTMS (auditory + prefrontal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory cortex only rTMS (AC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 32167976

Group type: EXPERIMENTAL
Intervention: Iloprost (20 μg) inhaled
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline inhaled (Control)
Number of subjects: 40
Study: 34783035

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation with hands near
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Overall pain rating
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation with hands far
Number of subjects: 27
Study: 34510226

Group type: EXPERIMENTAL
Intervention: Sitting less regimen (sitting 9 h/day, standing 4 h/day, walking 3 h/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exercise regimen (sitting 13 h/day, exercise 1 h/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sitting regimen (sitting 14 h/day)
Number of subjects: 12
Study: 32051312

Group type: EXPERIMENTAL
Intervention: Unblinded n-of-1 trial
Number of subjects: 90

Group type: COMPARATOR
Intervention: Blinded n-of-1 trial (positive control)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (negative control)
Number of subjects: 90
Study: 34651190

Group type: EXPERIMENTAL
Intervention: Levamisole 2.5mg/kg
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 33871635

Group type: EXPERIMENTAL
Intervention: Dietary fiber (DF) supplementation in low crude protein (CP) diet
Number of subjects: 77

Group type: COMPARATOR
Intervention: Low CP diet
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Dietary fiber (DF) supplementation
Number of subjects: 77
Study: 33035370

Group type: EXPERIMENTAL
Intervention: Agility Boot Camp with Cognitive Challenge (ABC-C) exercise program
Number of subjects: 82
Study: 32870957

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Task (PASAT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 15
Study: 34411333

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) treatment
Number of subjects: 27
Study: 32913154

Group type: COMPARATOR
Intervention: Intra-rectal xylocaine gel (10 mls)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Apical peri-prostatic nerve block (10 mls of 1% xylocaine)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2
Study: 35247264

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 2014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2014
Study: 32124566

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 0.3 g/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 0.6 g/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 1.2 g/kg SB
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Dietary SB supplementation
Number of subjects: 288

Group type: COMPARATOR
Intervention: CON, basal diet
Number of subjects: 288
Study: 35927706

Group type: EXPERIMENTAL
Intervention: 1% tetra sodium pyrophosphate
Number of subjects: 64

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 64
Study: 32875722

Group type: EXPERIMENTAL
Intervention: Partially guided surgery (PGS, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fully guided surgery (FGS, n = 12)
Number of subjects: 24
Study: 34404477

Group type: EXPERIMENTAL
Intervention: NMT
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: NMT plus EF
Number of subjects: 46
Study: 33026127

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Serum cortisol
Number of subjects: 32
Study: 34475868

Group type: EXPERIMENTAL
Intervention: Planned treatment interruption
Number of subjects: 8

Group type: COMPARATOR
Intervention: Continuous treatment
Number of subjects: 8
Study: 33891472

Group type: EXPERIMENTAL
Intervention: Atezolizumab 1,200 mg plus platinum-based chemotherapy (paclitaxel plus carboplatin) and bevacizumab 15 mg/kg
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Placebo plus platinum-based chemotherapy (paclitaxel plus carboplatin) and bevacizumab 15 mg/kg
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: Atezolizumab and placebo
Number of subjects: 1301
Study: 35768286

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) plus levocabastine nasal spray
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray (MFNS) plus placebo nasal spray
Number of subjects: 40
Study: 34446497

Group type: EXPERIMENTAL
Intervention: CytoSorb therapy (continuous for at least 24 hours, adsorber device changed every 12 hours)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: CytoSorb therapy (continuous for at least 24 hours, adsorber device changed every 24 hours)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 135
Study: 32386466

Group type: EXPERIMENTAL
Intervention: Group-based multimodal physical therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Primary-care physical therapy
Number of subjects: 62
Study: 37528476

Group type: EXPERIMENTAL
Intervention: Combined therapy of Er:YAG and long-pulsed Nd:YAG lasers
Number of subjects: 24

Group type: COMPARATOR
Intervention: Er:YAG laser therapy only
Number of subjects: 24
Study: 33017844

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF) for 8 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 39
Study: 35141517

Group type: EXPERIMENTAL
Intervention: Topical ethyl chloride spray (ECS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Subcutaneous 1% lidocaine injection (LI)
Number of subjects: 110
Study: 34521664

Group type: EXPERIMENTAL
Intervention: Inhaled amikacin (20 mg/kg daily for 3 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled placebo (0.9% Sodium Chloride)
Number of subjects: 0
Study: 32305094

Group type: EXPERIMENTAL
Intervention: LLINs with piperonyl butoxide (PBO)
Number of subjects: 5200
Study: 34551650

Group type: EXPERIMENTAL
Intervention: Turmeric root extract supplementation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35145610

Group type: EXPERIMENTAL
Intervention: Bathysmed® protocol (meditative scuba diving)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multisport program (control)
Number of subjects: 0
Study: 33600197

Group type: EXPERIMENTAL
Intervention: BMI + BA
Number of subjects: 113

Group type: COMPARATOR
Intervention: BMI + SC
Number of subjects: 113
Study: 33180863

Group type: EXPERIMENTAL
Intervention: Health education intervention group (n = 143)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group (n = 156)
Number of subjects: 299
Study: 36180836

Group type: EXPERIMENTAL
Intervention: Machine learning based on electronic health record (EHR) data directing supplemental clinical evaluations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard clinical workflow
Number of subjects: 0
Study: 34092234

Group type: EXPERIMENTAL
Intervention: Personalised nutrition advice (L1, L2, L3)
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Personalised nutrition advice (L3)
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Generalised dietary advice (control)
Number of subjects: 1270
Study: 32216150

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 23
Study: 35839214

Group type: EXPERIMENTAL
Intervention: Protein supplementation
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Protein supplementation and resistance training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Increasing physical activity (PA)
Number of subjects: 54
Study: 34874142

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite toothpaste
Number of subjects: 21

Group type: COMPARATOR
Intervention: Amine fluoride toothpaste
Number of subjects: 21
Study: 35636621

Group type: EXPERIMENTAL
Intervention: Decipher genomic classifier low–intermediate
Number of subjects: 350
Study: 32134342

Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR) with intra-operative CT scanning
Number of subjects: 0
Study: 36094783

Group type: EXPERIMENTAL
Intervention: Quarter-dose combination of amlodipine, telmisartan, and chlorthalidone
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Half-dose combination of amlodipine, telmisartan, and chlorthalidone
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Third-dose combination of amlodipine, telmisartan, and chlorthalidone
Number of subjects: 176

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 33155348

Group type: EXPERIMENTAL
Intervention: Culturally Adapted Cognitive Behavioral Therapy Plus Problem Management (CA-CBT+)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 24
Study: 36920567

Group type: EXPERIMENTAL
Intervention: taVNS (transcutaneous auricular vagus nerve stimulation)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation (earlobe stimulation)
Number of subjects: 22
Study: 34400673

Group type: EXPERIMENTAL
Intervention: Normalization with GLY1 and SKP1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional RGs (eIF1α and ACT2)
Number of subjects: 0
Study: 35794487

Group type: EXPERIMENTAL
Intervention: Peloid therapy and home exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Paraffin therapy and home exercise
Number of subjects: 80
Study: 34582572

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 5601

Group type: COMPARATOR
Intervention: Regional anaesthesia
Number of subjects: 5601
Study: 33355078

Group type: EXPERIMENTAL
Intervention: Tranexamic acid administration at the beginning of RARP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no tranexamic acid)
Number of subjects: 100
Study: 34775453

Group type: EXPERIMENTAL
Intervention: Implantable collamer lens (ICL) V4c
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refractive implantable lens (RIL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both ICL and RIL
Number of subjects: 50
Study: 32741375

Group type: EXPERIMENTAL
Intervention: Prefabricated contoured foot orthoses
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flat shoe insoles
Number of subjects: 40
Study: 33686160

Group type: EXPERIMENTAL
Intervention: Nonadherent group (n=59)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Adherent group (n=33)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Adherence measured by MEMS
Number of subjects: 92
Study: 32040244

Group type: EXPERIMENTAL
Intervention: CBT-E
Number of subjects: 143

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 143
Study: 36493504

Group type: EXPERIMENTAL
Intervention: Punitive parenting behaviors during drinking events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive parenting behaviors the morning after drinking
Number of subjects: 0
Study: 34100149

Group type: EXPERIMENTAL
Intervention: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) 800/150/200/10 mg
Number of subjects: 1106
Study: 35631257

Group type: EXPERIMENTAL
Intervention: Ferric sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate, and selenomethionine (Group 2; N = 22)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral ferrous sulfate (Group 1; N = 20)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Ferric liposomal formulation (Group 3; N = 20)
Number of subjects: 62
Study: 34186278

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided retrolaminar block (RLB)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Ilioinguinal nerve block (INB)
Number of subjects: 65
Study: 35630079

Group type: EXPERIMENTAL
Intervention: Individually tailored 12-week remote physiotherapy program
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (continued target medical therapy only)
Number of subjects: 21
Study: 34611847

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) - 20 sessions on the right supplementary motor area
Number of subjects: 12
Study: 32004757

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 0
Study: 32089822

Group type: EXPERIMENTAL
Intervention: MVA-NP+M1 co-administered with licensed inactivated quadrivalent influenza vaccine
Number of subjects: 2030

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 2030
Study: 35042370

Group type: EXPERIMENTAL
Intervention: NAMI Basics (peer-led family support program)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Waitlist condition (control group)
Number of subjects: 111
Study: 33580623

Group type: EXPERIMENTAL
Intervention: Perioperative FOLFOX (four cycles before surgery and eight cycles after)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Adjuvant FOLFOX (upfront surgery)
Number of subjects: 104
Study: 32178765

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg every 4 weeks
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg every 8 weeks
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study: 33292022

Group type: EXPERIMENTAL
Intervention: PCSO‐524® (600 mg/d)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: ESPO‐572® (600 mg/d)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: ESPO‐572®
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: PCSO‐524®
Number of subjects: 51
Study: 34503857

Group type: EXPERIMENTAL
Intervention: Patient-specific surgical guides and pre-bent titanium miniplates
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional interocclusal wafers with intraoperatively adapted titanium miniplates
Number of subjects: 20
Study: 35212055

Group type: EXPERIMENTAL
Intervention: Online self-help intervention website
Number of subjects: 205

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 205
Study: 32221684

Group type: EXPERIMENTAL
Intervention: Absorbable biliary stents
Number of subjects: 159
Study: 35049070

Group type: EXPERIMENTAL
Intervention: Single-dose rituximab (S-Rtx) 375 mg/m2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose rituximab (LD-Rtx) 100 mg weekly for 4 weeks
Number of subjects: 0
Study: 33483115

Group type: EXPERIMENTAL
Intervention: Immediate-use App group (iApp group; n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed-use App group (dApp group; n = 25)
Number of subjects: 50
Study: 35258579

Group type: EXPERIMENTAL
Intervention: Pulsed low-intensity ultrasonography (PLIUS) for 48 weeks, self-administered for 20 minutes daily.
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sham ultrasonography for 48 weeks, self-administered for 20 minutes daily.
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Pulsed low-intensity ultrasonography (PLIUS) for 48 weeks.
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sham ultrasonography for 48 weeks.
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Pulsed low-intensity ultrasonography (PLIUS) and Sham ultrasonography.
Number of subjects: 132
Study: 32209068

Group type: EXPERIMENTAL
Intervention: Thoracic spinal mobilization (2 Hz) for 2 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham ultrasound therapy for 2 minutes
Number of subjects: 30
Study: 35049249

Group type: EXPERIMENTAL
Intervention: Curcuma longa (curcumin) 200 mg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Mefenamic acid (MA) 500 mg
Number of subjects: 76
Study: 34189834

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both GLP-1 RAs
Number of subjects: 50
Study: 32285710

Group type: EXPERIMENTAL
Intervention: Energy drink (250 mL Red Bull)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Water (250 mL)
Number of subjects: 42
Study: 33879118

Group type: EXPERIMENTAL
Intervention: 2-weekly mobile phone calls
Number of subjects: 150

Group type: COMPARATOR
Intervention: No phone calls (control)
Number of subjects: 150
Study: 32900671

Group type: EXPERIMENTAL
Intervention: Internet-administered Cognitive Behavioral Therapy (ICBT) for 12 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hypersexual Behavior Inventory (HBI-19)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hypersexual Disorder: Current Assessment Scale (HD:CAS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sexual Compulsivity Scale (SCS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Montgomery-Åsberg Depression Rating Scale (MADRS-S)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Client Satisfaction Questionnaire (CSQ-8)
Number of subjects: 36
Study: 34085898

Group type: EXPERIMENTAL
Intervention: Discrimination level among participants
Number of subjects: 2377

Group type: EXPERIMENTAL
Intervention: Discrimination level by sex
Number of subjects: 2377

Group type: EXPERIMENTAL
Intervention: Discrimination level by age
Number of subjects: 2377

Group type: EXPERIMENTAL
Intervention: Discrimination level by occupation
Number of subjects: 2377

Group type: EXPERIMENTAL
Intervention: Discrimination level by region
Number of subjects: 2377

Group type: EXPERIMENTAL
Intervention: Discrimination level by knowledge scores
Number of subjects: 2377
Study: 34530800

Group type: EXPERIMENTAL
Intervention: Combined intervention (health literacy and CRC training + brochure and video for eligible patients)
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1024
Study: 36083488

Group type: EXPERIMENTAL
Intervention: Wenshen Jianpi recipe (WJR) combined with antiretroviral therapy (ART)
Number of subjects: 56
Study: 35022170

Group type: EXPERIMENTAL
Intervention: Intervention based on the PMT-IMB model
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standardised antenatal care (ANC)
Number of subjects: 800
Study: 34859631

Group type: EXPERIMENTAL
Intervention: Dental General Anesthesia (DGA)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Routine outpatient treatment
Number of subjects: 2
Study: 32340472

Group type: EXPERIMENTAL
Intervention: Genetic elevation of birthweight (1-SD increase)
Number of subjects: 0
Study: 36197155

Group type: EXPERIMENTAL
Intervention: Quarter heel raising exercise (QHR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 33789728

Group type: EXPERIMENTAL
Intervention: Fluralaner (Exzolt®; 0.5 mg/kg body weight) administered twice, 7 days apart via drinking water.
Number of subjects: 47000

Group type: EXPERIMENTAL
Intervention: Fluralaner treatment
Number of subjects: 47000
Study: 32641079

Group type: EXPERIMENTAL
Intervention: Blood transfusion from male donors aged < 25 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood transfusion from male donors aged 25-45 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood transfusion from male donors aged > 45 years
Number of subjects: 0
Study: 34735596

Group type: EXPERIMENTAL
Intervention: Two-surgeon bilateral TKA
Number of subjects: 136

Group type: COMPARATOR
Intervention: Single-surgeon bilateral TKA
Number of subjects: 136
Study: 33259933

Group type: EXPERIMENTAL
Intervention: Radical hemithoracic radiation therapy (RHR)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Palliative radiation therapy (PR)
Number of subjects: 108
Study: 35499271

Group type: EXPERIMENTAL
Intervention: Videos plus home laparoscopic box trainer
Number of subjects: 17

Group type: COMPARATOR
Intervention: Videos alone
Number of subjects: 17
Study: 32851572

Group type: EXPERIMENTAL
Intervention: NOACs
Number of subjects: 6095

Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists
Number of subjects: 6095

Group type: EXPERIMENTAL
Intervention: Parenteral therapy
Number of subjects: 6095

Group type: EXPERIMENTAL
Intervention: Other anticoagulant treatments
Number of subjects: 6095
Study: 33055515

Group type: EXPERIMENTAL
Intervention: E‐Scoop spectacle lens
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190
Study: 35675073

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Gemcitabine plus nab-paclitaxel
Number of subjects: 1102
Study: 36253778

Group type: EXPERIMENTAL
Intervention: Morning vaccination
Number of subjects: 389
Study: 32198301

Group type: COMPARATOR
Intervention: Mesenchymal stem cell (MSC) therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Method of administration (intravascular vs intracerebral)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Goal of the trial (efficacy vs safety)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Screening for the trial by physicians
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Time-related barriers and resource needs identified by physicians
Number of subjects: 28
Study: 35124654

Group type: EXPERIMENTAL
Intervention: Bryostatin treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95